DC-SIGN/CD209 Antikörper (PE)
Kurzübersicht für DC-SIGN/CD209 Antikörper (PE) (ABIN2479244)
Target
Alle DC-SIGN/CD209 (CD209) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG conjugated to R. Phycoerythrin (RPE)
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
-
-
: "Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 4, pp. 2192-200, (2011) (PubMed).
: "DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 168, Issue 6, pp. 2634-43, (2002) (PubMed).
: "An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas." in: Cancer research, Vol. 62, Issue 11, pp. 3167-74, (2002) (PubMed).
-
: "Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 4, pp. 2192-200, (2011) (PubMed).
-
- DC-SIGN/CD209 (CD209) (CD209)
-
Andere Bezeichnung
- CD209
-
Hintergrund
- Synonyms: DC-SIGN
-
Gen-ID
- 30835
-
UniProt
- Q9NNX6
Target
-